Symphony Dynamo
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Symphony Dynamo - overview
Established
2006
Location
Rockville, MD-Maryland, US
Primary Industry
Biotechnology
About
Symphony Dynamo, is based in Rockville, US and is a biopharmaceutical company, engages in the clinical development of therapeutics to treat hepatitis B, hepatitis C, and cancer.
Current Investors
Dynavax Technologies Corporation
Primary Industry
Biotechnology
Sub Industries
Biopharmaceuticals
Company Stage
Add-on
Total Amount Raised
Subscriber access only
Symphony Dynamo - deals
| Deals Type | Deal Status | Target (s) | Deal Date | Investor(s) | Seller(s) | Deal size (Mn) | Enterprise value (Mn) | Post-money valuation (Mn) | EBITDA multiple (x) | Revenue multiple (x) | Lead partner (s) |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Add-on, Trade Sale | Completed | Symphony Dynamo | - | ||||||||
| Unspecified Round | Completed | Symphony Dynamo | - |
Displaying 1 - 2 of 2
Symphony Dynamo - employee data
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.